Understanding patterns of pathologic response following neoadjuvant immunotherapy for solid tumors

Ann Oncol. 2018 Aug 1;29(8):1630-1632. doi: 10.1093/annonc/mdy227.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Breast Neoplasms*
  • Carcinoma, Non-Small-Cell Lung*
  • Humans
  • Immunotherapy
  • Lung Neoplasms*
  • Neoadjuvant Therapy
  • Programmed Cell Death 1 Receptor

Substances

  • Programmed Cell Death 1 Receptor